Joshua Jennings
Stock Analyst at TD Cowen
(1.29)
# 1631
Out of 5,240 analysts
74
Total ratings
43.14%
Success rate
11.95%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Anteris Technologies | Initiates Coverage On: Buy | 15 | 5.63 | 166.43% | 1 | Jan 7, 2025 | |
Insulet | Maintains: Strong Buy | 264 324 | 267.3 | 21.21% | 1 | Jan 3, 2025 | |
Boston Scientific | Maintains: Strong Buy | 100 110 | 95.55 | 15.12% | 6 | Dec 12, 2024 | |
CeriBell | Maintains: Strong Buy | 31 36 | 19.1 | 88.48% | 2 | Dec 9, 2024 | |
TransMedics Gr | Maintains: Buy | 175 120 | 62.57 | 91.79% | 9 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 4.11 | 143.31% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 50 | 3.13 | 1497.44% | 1 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 75 99 | 81.58 | 21.35% | 3 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 143 119 | 104.65 | 13.71% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 55 60 | 58.63 | 2.34% | 2 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 83 80 | 72.67 | 10.09% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 9 3 | 0.81 | 270.37% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 100 70 | 71.02 | -1.44% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 195 185 | 144.67 | 27.88% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 40 | 30.61 | 30.68% | 3 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 365 400 | 362.71 | 10.28% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 60 | 33.16 | 80.94% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 52 34 | 35.79 | -5% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 14 18 | 7.27 | 147.59% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 114 125 | 79.23 | 57.77% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 13 10 | n/a | n/a | 2 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 25 | 19.1 | 30.89% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 130 130 | 113.03 | 15.01% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 7 5 | 2.08 | 140.38% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 360 120 | n/a | n/a | 1 | Jun 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 125 117 | 85.13 | 37.44% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 450 | 12.84 | 3404.67% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 30 31 | n/a | n/a | 1 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 20 | n/a | n/a | 1 | Nov 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 12 | 11.08 | 8.3% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 306 275 | 235.82 | 16.61% | 1 | Feb 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 28 28 | n/a | n/a | 2 | Sep 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 11000 | n/a | n/a | 1 | May 3, 2017 |